Definium Therapeutics, Inc.: common_shares_outstanding

Value{"unit": "shares", "value": 38063385, "concept": "dei:EntityCommonStockSharesOutstanding"}
Period (as of 2023-02-22)
Statuscurrent
EntityDefinium Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-007053 · Open the official SEC filing →
Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001813814/common-shares-outstanding/2023-02-22 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/7b28a5ed-cbdb-4e12-a2c1-06ad39402e9e

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies